1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Autoantibodies as prognostic markers in rheumatoid arthritis
(
- Contribution to journal › Scientific review
-
Mark
Autoantibodies to joint-related peptides as predictive markers in early rheumatoid arthritis
(
- Contribution to journal › Article
- 2024
-
Mark
Effectiveness of JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis : Results From a Nationwide Swedish Cohort Study
2024) In Arthritis and Rheumatology(
- Contribution to journal › Article
-
Mark
Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritis
(
- Contribution to journal › Article
- 2023
-
Mark
Antibodies against Porphyromonas gingivalis in serum and saliva and their association with rheumatoid arthritis and periodontitis. Data from two rheumatoid arthritis cohorts in Sweden
(
- Contribution to journal › Article
-
Mark
Pathogenic antibody response to glucose-6-phosphate isomerase targets a modified epitope uniquely exposed on joint cartilage
(
- Contribution to journal › Article
-
Mark
Autoantibodies to Disease-Related Proteins in Joints as Novel Biomarkers for the Diagnosis of Rheumatoid Arthritis
(
- Contribution to journal › Article
-
Mark
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis : 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
(
- Contribution to journal › Article
- 2021
-
Mark
Autoantibodies in Rheumatoid Arthritis – Laboratory and Clinical Perspectives
(
- Contribution to journal › Scientific review
-
Mark
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population : A nationwide Swedish cohort study
(
- Contribution to journal › Article